Founded Year

2012

Stage

Incubator/Accelerator - II | Alive

Total Raised

$9.83M

About QUIBIM

Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

QUIBIM Headquarter Location

Avenida Aragón 30 13 Floor, Office I - J

Valencia, 46021,

Spain

+34 961 243 225

QUIBIM's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

QUIBIM's Products & Differentiation

See QUIBIM's products and how their products differentiate from alternatives and competitors

  • QP-Prostate

    Tool for performing AI based prostate MRI interpretation, taking prostate cancer reporting from 40-45 mins down to 5 minutes

    Differentiation

    Unique solution that performes a regional analysis of the prostate instead of considering the whole gland as a single region. Prostate cancer staging depends on the location of the tumor (transition… 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing QUIBIM

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

QUIBIM is included in 7 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

11,772 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

H

Health Monitoring & Diagnostics

2,707 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

8,260 items

QUIBIM Patents

QUIBIM has filed 1 patent.

The 3 most popular patent topics include:

  • Magnetic resonance imaging
  • Medical imaging
  • Medical physics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/17/2020

Medical imaging, Neuroimaging, Radiology, Magnetic resonance imaging, Medical physics

Application

Application Date

1/17/2020

Grant Date

Title

Related Topics

Medical imaging, Neuroimaging, Radiology, Magnetic resonance imaging, Medical physics

Status

Application

Latest QUIBIM News

Spanish-owned life sciences pioneers invest in Cambridge with help from Growth Works

Apr 21, 2022

21-04-2022 A leading Spanish-owned life sciences company has chosen Cambridge for its first expansion to the UK following support from the Combined Authority and Business Board’s dedicated business growth service Growth Works and other partners. Quibim, a global leader in whole-body medical imaging, has located to the Bradfield Centre at Cambridge Science Park, with a commitment to create more than 10 jobs over the next few years. Last summer, the Growth Works Business Growth Service launched an international market access programme for life sciences companies around the world that were looking to scale and grow into new markets. This was run through its international inward investment brand, Locate Cambridge. This programme was oversubscribed, and 10 companies out of more than 30 applicants were shortlisted to pitch to a panel of experts to facilitate and accelerate the companies’ journey into the region. Quibim was one of the successful participants in the programme and pitched to a panel consisting of Start Codon, Illumina, Eastern Academic Health Science Network (AHSN) and a dealmaker and mentor from the Department of International Trade’s Global Entrepreneurship Programme. Quibim’s advanced whole-body medical imaging is done through the use of AI-guided image analysis to discover critical and evasive health indicators. The company works with top biopharma players to develop new imaging based diagnostic algorithms in a value-based, long-term model of partnership. Once the new AI models are validated, they are regulatory cleared as a medical device and marketed to providers. Collectively, the Growth Works programme through its Locate Cambridge Brand and its strategic partner, Eastern AHSN, which is funded by the NHS and the Government’s Office for Life Sciences, supported Quibim in its decision to locate in Cambridge rather than other parts of the UK. The access to skills, innovation partners and access to capital also contributed to their decision to invest. Quibim began their supportive partnership with Eastern AHSN after being selected to present their innovation at their Innovation Review Panel. Quibim’s flagship product, QP-Prostate was identified as having a strategic fit to the region’s health and care priorities with prostate cancer being part of the NHS operational and delivery plan priorities for the current year. Quibim was further accepted into the 3rd annual scale-up academy cohort run by Eastern AHSN in partnership with the Triple Chasm Company. This prestigious programme provides companies evidence based tools and coaching. Over the 6-week programme Quibim was able to identify the key drivers for growth that they needed to focus on and were able to draw up an approach to achieve their desired sprint past the development chasms often faced by innovators to progress an accelerated scale-up journey. Overall, Eastern AHSN has helped Quibim access their wide network and brokered independent engagement meetings where NHS Trusts are keen to trial the QP-Prostate product. This support is helping establish Quibim as a high-quality solution provider of world class imaging services in our region. Dr Angel Alberich, CEO of Quibim said: “We are excited on starting our operations in UK and have been really motivated by the support received from Eastern AHSN as well as the British embassy in Spain. Cambridge was definitely our choice because of the life sciences ecosystem as well as the balance between the excellent research environment and quality of life.” Austen Adams, chair of the Business Board, said: “Growing our globally competitive Life Sciences industry is a key aim of the Business Board. It is fantastic news that our dedicated inward investment service through Growth Works has been able to help support such an innovative and pioneering company to invest in our region. “I look forward to working with the Quibim team and hearing more about their plans for future growth and job creation.” Rebecca Bekkenutte, Managing Director of Growth Works said: “This is the outcome that makes the Growth Works and its International Locate Cambridge Programme such a positive outcome for the entire region. It also showcases how the wider support mechanism of the wider Cambridgeshire and Peterborough ecosystem come together to attract high growth and innovative companies into the area. We all have our part to play to ensure a smooth transition and set up for the companies with which we work. Dr. Louise Jopling, Commercial Director at the Eastern AHSN (Academic Health Science Network) said: “As a trusted partner to the NHS who understands their priorities and pressures, we have helped Quibim introduce their innovations in a way that resonates and have enjoyed helping establish them as a provider of leading imaging services in our region.”   The Combined Authority is made up of eight founding members across Cambridgeshire and Peterborough. Each partner is represented by their leader at Combined Authority meetings. Cambridgeshire & Peterborough Combined Authority

QUIBIM Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

QUIBIM Rank

  • When was QUIBIM founded?

    QUIBIM was founded in 2012.

  • Where is QUIBIM's headquarters?

    QUIBIM's headquarters is located at Avenida Aragón 30, Valencia.

  • What is QUIBIM's latest funding round?

    QUIBIM's latest funding round is Incubator/Accelerator - II.

  • How much did QUIBIM raise?

    QUIBIM raised a total of $9.83M.

  • Who are the investors of QUIBIM?

    Investors of QUIBIM include Conector Accelerator, Philips Healthworks, Angels Capital, Tech Transfer UPV, Bioimaging Ventures and 11 more.

  • Who are QUIBIM's competitors?

    Competitors of QUIBIM include Cleerly, Lunit, Aidoc Medical, Owkin, Qure.ai, Viz.ai, Quantib, SenseTime, Overjet, Iterative Scopes and 35 more.

  • What products does QUIBIM offer?

    QUIBIM's products include QP-Prostate and 2 more.

  • Who are QUIBIM's customers?

    Customers of QUIBIM include Janssen.

You May Also Like

A
Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

Ultromics Logo
Ultromics

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

I
Imagen Technologies

Imagen is building a world without diagnostic errors. The company is beginning by applying the latest advances in computer vision and machine learning to medical imaging. Imagen Technologies is putting leading medical expertise in the hands of healthcare providers everywhere.

Infervision Logo
Infervision

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Koios Medical Logo
Koios Medical

Koios Medical is a provider of software solutions for radiologists diagnosing cancer. Using AI algorithms trained on thousands of images combined with data from pathology results, Koios DS™ is decision support for healthcare diagnostics.

R
RadNet

RadNet is a national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. The company has a network of 293 owned and/or operated outpatient imaging centers.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.